Research conducted at the Wayne State University School of Medicine has helped confirm the effectiveness of a blood biomarker that can indicate if patients with a head injury can avoid a costly CT scan because the blood test results indicate no traumatic brain injury (TBI).
The findings, published online in The Lancet Neurology on July 24, validated the use of a diagnostic blood test developed by Banyan Biomarkers Inc. to rule out the need for a head CT scan in patients 18 years and older with suspected TBI. The results support the potential clinical role of the biomarker test to dramatically reduce the need to order CT scans of the head, cutting patient exposure to radiation and health care costs for unnecessary scans.
Link: Full Article – New Blood Test Helps Patients with Traumatic Head Injury Avoid Costly CT Scan